Simon Pimstone's Insider Trades & SAST Disclosures
Simon Pimstone's most recent trade in Xenon Pharmaceuticals Inc was a trade of 18,475 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 2, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Simon Pimstone.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 18,475 | 18,475 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.76 per share. | 30 May 2023 | 50,000 | 56,000 (0%) | 0% | 17.8 | 888,000 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2023 | 50,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.76 per share. | 30 May 2023 | 45,000 | 51,000 (0%) | 0% | 17.8 | 799,200 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2023 | 45,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.85 per share. | 30 May 2023 | 29,835 | 35,835 (0%) | 0% | 9.9 | 293,875 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2023 | 29,835 | 0 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 38.69 per share. | 30 May 2023 | 26,856 | 6,000 (0%) | 0% | 38.7 | 1,039,059 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 38.78 per share. | 30 May 2023 | 24,255 | 6,000 (0%) | 0% | 38.8 | 940,609 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 38.81 per share. | 30 May 2023 | 23,670 | 6,000 (0%) | 0% | 38.8 | 918,633 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.37 per share. | 30 May 2023 | 23,144 | 32,856 (0%) | 0% | 38.4 | 888,035 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.53 per share. | 30 May 2023 | 20,745 | 30,255 (0%) | 0% | 38.5 | 799,305 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 39.90 per share. | 30 May 2023 | 19,000 | 18,000 (0%) | 0% | 39.9 | 758,100 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 38.63 per share. | 30 May 2023 | 18,006 | 37,000 (0%) | 0% | 38.6 | 695,572 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 38.53 per share. | 30 May 2023 | 12,000 | 6,000 (0%) | 0% | 38.5 | 462,360 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.69 per share. | 30 May 2023 | 9,318 | 15,318 (0%) | 0% | 7.7 | 71,655 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2023 | 9,318 | 30,682 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 38.97 per share. | 30 May 2023 | 7,458 | 6,000 (0%) | 0% | 39.0 | 290,638 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.37 per share. | 30 May 2023 | 6,165 | 29,670 (0%) | 0% | 38.4 | 236,551 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.53 per share. | 30 May 2023 | 1,860 | 13,458 (0%) | 0% | 38.5 | 71,666 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2023 | 41,152 | 0 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.68 per share. | 07 Mar 2023 | 41,152 | 47,152 (0%) | 0% | 2.7 | 110,287 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.59 per share. | 07 Mar 2023 | 30,864 | 64,866 (0%) | 0% | 2.6 | 79,938 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2023 | 30,864 | 0 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 37.01 per share. | 07 Mar 2023 | 10,990 | 34,002 (0%) | 0% | 37.0 | 406,740 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 36.94 per share. | 07 Mar 2023 | 8,242 | 55,006 (0%) | 0% | 36.9 | 304,459 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.13 per share. | 07 Mar 2023 | 2,160 | 44,992 (0%) | 0% | 37.1 | 80,201 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.13 per share. | 07 Mar 2023 | 1,618 | 63,248 (0%) | 0% | 37.1 | 60,076 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 38.60 per share. | 12 Aug 2022 | 47,000 | 93,000 (0%) | 0% | 38.6 | 1,814,200 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 37.91 per share. | 12 Aug 2022 | 43,135 | 140,000 (0%) | 0% | 37.9 | 1,635,248 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 37.76 per share. | 12 Aug 2022 | 33,942 | 58,058 (0%) | 0% | 37.8 | 1,281,650 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 38.29 per share. | 12 Aug 2022 | 32,058 | 26,000 (0%) | 0% | 38.3 | 1,227,501 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 38.87 per share. | 12 Aug 2022 | 20,000 | 6,000 (0%) | 0% | 38.9 | 777,400 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 39.15 per share. | 12 Aug 2022 | 1,000 | 92,000 (0%) | 0% | 39.2 | 39,150 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2022 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 30.80 per share. | 04 Mar 2022 | 2,500 | 193,135 (0%) | 0% | 30.8 | 77,000 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director | Sale of securities on an exchange or to another person at price $ 31.33 per share. | 15 Nov 2021 | 17,557 | 210,186 (0%) | 0% | 31.3 | 550,061 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 22,633 | 0 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. | 24 May 2021 | 22,633 | 232,819 (0%) | 0% | 3.8 | 85,100 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.17 per share. | 24 May 2021 | 5,076 | 227,743 (0%) | 0% | 19.2 | 97,307 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director, CEO | Other type of transaction at price $ 0.00 per share. | 20 Aug 2020 | 45,000 | 210,186 (0%) | 0% | 0 | Common Shares | |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director, CEO | Sale of securities on an exchange or to another person at price $ 13.99 per share. | 29 May 2020 | 5,000 | 258,186 (0%) | 0% | 14.0 | 69,950 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director, CEO | Sale of securities on an exchange or to another person at price $ 14.43 per share. | 29 May 2020 | 3,000 | 255,186 (0%) | 0% | 14.4 | 43,290 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.56 per share. | 26 May 2020 | 6,172 | 264,294 (0%) | 0% | 3.6 | 21,972 | Common Shares |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2020 | 6,172 | 0 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Simon Pimstone | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.90 per share. | 26 May 2020 | 1,108 | 263,186 (0%) | 0% | 14.9 | 16,509 | Common Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges